EBSOLYR

Janssen Sciences Ireland Unlimited Company

Application Filed: 2018-10-22
Trademark Application Details
Trademark Logo EBSOLYR

Mark For: EBSOLYR™ trademark registration is intended to cover the categories of human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives. [all]

Status

2021-05-27 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88163579
Mark Literal ElementsEBSOLYR
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2019-05-07
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameCheryl L. Foytlin
Attorney Docket NumberT44224US1
Law Office AssignedM60
Employee NameGAYNOR, BARBARA ANNE

Timeline

2018-10-22Application Filed
2019-03-12Published
2019-03-12Published for Opposition
2019-05-07Location: INTENT TO USE SECTION
2019-10-16Status: Live/Pending
2019-10-18Transaction Date
2021-03-29Status: A fourth request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Janssen Sciences Ireland Unlimited Company
AddressBarnahely Ringaskiddy, Co. Cork IRELAND
Legal Entity TypePrivate Unlimited Company
Legal Entity StateIRELAND

Documents

DrawingJPEG2018-10-22
TEAS RF New ApplicationMULTI2018-10-22
Notation to FileXML2019-01-30
XSearch Search SummaryXML2019-01-30
TRAM Snapshot of App at Pub for OppostnMULTI2019-01-31
Notice of PublicationXML2019-02-20
Notification Of Notice of PublicationXML2019-02-20
OG Publication ConfirmationAPPLICATION/XML2019-03-12
Notice of AllowanceAPPLICATION/XML2019-05-07
Extension of Time to File SOUAPPLICATION/XML2019-10-16
ITU Extension ApprovalAPPLICATION/XML2019-10-18
ITU Unit ActionMULTI2019-10-18
Extension of Time to File SOUAPPLICATION/XML2020-04-14
ITU Extension ApprovalAPPLICATION/XML2020-04-16
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2020-04-16
Extension of Time to File SOUAPPLICATION/XML2020-10-27
ITU Extension ApprovalAPPLICATION/XML2020-10-29
ITU Unit ActionMULTI2020-10-29
Extension of Time to File SOUAPPLICATION/XML2021-03-29
ITU Extension ApprovalAPPLICATION/XML2021-03-31
ITU Unit ActionMULTI2021-03-31

Attorney of Record

CHERYL L. FOYTLIN
JOHNSON & JOHNSON
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK NJ 08933-7001

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-03-31
TEAS EXTENSION RECEIVED2021-03-29
EXTENSION 4 GRANTED2021-03-2998765
EXTENSION 4 FILED2021-03-2998765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-10-29
TEAS EXTENSION RECEIVED2020-10-27
EXTENSION 3 GRANTED2020-10-2798765
EXTENSION 3 FILED2020-10-2798765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-04-16
TEAS EXTENSION RECEIVED2020-04-14
EXTENSION 2 GRANTED2020-04-1498765
EXTENSION 2 FILED2020-04-1498765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-10-18
TEAS EXTENSION RECEIVED2019-10-16
EXTENSION 1 GRANTED2019-10-1698765
EXTENSION 1 FILED2019-10-1698765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-05-07
PUBLISHED FOR OPPOSITION2019-03-12
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-03-12
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-02-20
ASSIGNED TO EXAMINER2019-01-3072508
APPROVED FOR PUB - PRINCIPAL REGISTER2019-01-30
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-11-02
NEW APPLICATION ENTERED IN TRAM2018-10-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed